US Patent Issued to MYELOID THERAPEUTICS on June 3 for "Methods and compositions for genomic integration" (Massachusetts Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,925, issued on June 3, was assigned to MYELOID THERAPEUTICS INC. (Cambridge, Mass.).

"Methods and compositions for genomic integration" was invented by Daniel Getts (Stow, Mass.), Yuxiao Wang (Belmont, Mass.), Namita Bisaria (Somerville, Mass.), Inna Shcherbakova (Holliston, Mass.) and Socheata Ly (North Billerica, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and composition for modulating a target genome and stable integration of a transgene of interest into the genome of a cell are disclosed."

The patent was filed on Jan. 19, 2023, under Application No. 18/157,052.

*For further information, including images, charts and tables, ple...